Description
This session will focus on contemporary evidence evaluating outcomes in patients on DOACS vs. LAAO as well as procedural considerations and thromboembolic risk in patients undergoing LAAO.
Learning Objectives
- Explore the safety and efficacy of DOACs vs. LAAO included contemporary insights from the OPTION Trial.
- Summarize procedural outcomes associated with LAAO including the incidence and predictors of peridevice leaks.
- Explain how the geometric size and shape of the left atrial appendage can influence thrombogenicity and arrhythmogencity in patients with AF.
Session Chair(s)
Michael Ezekowitz, MBChB, DPhil
Presentation
Comparison of Left Atrial Appendage Closure and Oral Anticoagulation after Catheter Ablation for Atrial Fibrillation: Concomitant and Sequential Cohorts of the OPTION Randomized Controlled Trial
Presenter(s): Walid I. Saliba, MD, Devi G. Nair, MD, Vijendra Swarup, MD, Terri Hall, Vivek Iyer, German Calle Perez, Stanislav Weiner, MD, Manish H. Shah, MD, Nilofar Islam, Marek Grygier, Brian Schuler, MD, Jose Luis Ibanez Criado, Guillaume Duthoit, Yeruva V. Reddy, MD, Kristine Roy, PhD, Thomas Christen, Brad Sutton, MBA, MD, Oussama M. Wazni, MD
Long-Term Outcomes of LAAO vs. DOACs in Patients with Obesity and Atrial Fibrillation: A 5-Year Propensity-Matched Analysis
Presenter(s): Issam Motairek, Chadi Tabaja, MD, Astefanos Al-Dalakta, MD, Arwa Younis, MD, Abdel Hadi El Hajjar, MD, Osamah Badwan, MD, Adele Watfa, MD, Mohamad Mdaihly, MD, Ayman A. Hussein, MD, Tyler Louis. Taigen, MD, John Rickard, MBA, MD, MPH, Mandeep Bhargava, MD, Mohamed Kanj, MD, Bryan Baranowski, MD, Shady Nakhla, MD, Pasquale Santangeli, MD, PhD, Mina K. Chung, MD, Walid I. Saliba, MD, Oussama M. Wazni, MD
Predictors and Incidence of Progression of Peri-device leak after Left Atrial Appendage Occlusion
Presenter(s): Daisuke Togashi, Christopher R. Ellis, MD, Gregory Jackson, Yumi Katsume, MD, Salah H. Alahwany, MD, MSci, PhD, Micheal Baker, Arvindh N. Kanagasundram, MD
The size of the Left Atrial Appendage Stump is Predictive of Systemic Thromboembolism and Arrhythmogenicity in Patients with Atrial Fibrillation and Epicardial Exclusion
Presenter(s): Rajesh Kabra, MD, Aashish Katapadi, MD, Jalaj Garg, MD, Naga Venkata Krishna Chand. Pothineni, MD, Douglas Darden, MD, Scott Koerber, DO, Rakesh Gopinathannair, MA, MD, Rangarao V. Tummala, MBBS, Peter H. Park, MD, Donita Atkins, BS, BSN, RN, Sudha Bommana, CCRP, Luigi Di Biase, MD, PhD, Andrea Natale, MD, Dhanunjaya R. Lakkireddy, MBA, MD
Refractory Left Atrial Appendage Thrombi: Combined Mechanical Vacuum Aspiration and Left Atrial Appendage Closure
Presenter(s): Maryam Saleem, MD, Nana Gegechkori, MD, Sai Krishna Reddy Seemala, William Whang, MD, Sam Hanon, MD, Mohit K. Turagam, MD, Jacob S. Koruth, MD, Daniel Ross. Musikantow, MD, Srinivas R. Dukkipati, MD, Marc A. Miller, MD, Vivek Y. Reddy, MD
Disclosures
Walid Saliba:
- Biosense Webster, Inc. (Honoraria/Speaking/Consulting Fee - Membership on Advisory Committees or Review Panels)
- Boston Scientific (Honoraria/Speaking/Consulting Fee - Membership on Advisory Committees or Review Panels)
Issam Motairek:
- Nothing Relevant to Disclose
Daisuke Togashi:
- Nothing Relevant to Disclose
Aashish Katapadi:
- Nothing Relevant to Disclose
Maryam Saleem:
- Nothing Relevant to Disclose
To view all Heart Rhythm 2025 Faculty Disclosures, please click
here.